References
1 – https://www.futuremedicine.com/doi/10.2217/pgs-2019-0134
2 – https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html
3 – https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-73
4 – https://pubmed.ncbi.nlm.nih.gov/24798722/
5 – https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling
6 – https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255642
7 – https://www.reuters.com/article/us-bristol-myers-sanofi-plavix-idUSKBN2AF1YI